The vast majority of healthcare data isn't used because it's difficult to work with, according to Beth Andrews, chief digital health officer of life sciences and healthcare at Dell Technologies. Andrews made these comments during a session at the MedCity News INVEST Digital Health conference.
Integral raked in $6.9 million in seed funding in this week. The San Francisco-based startup is developing technology that seeks to speed up the process of exchanging sensitive health data while still maintaining robust privacy protection.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Innovaccer launched a new product called Sara, a conversational AI assistant designed to help executives at health systems and payers make better use of their data. It allows executives can ask complex questions about their organization’s patients or members and get immediate answers on clinical, financial or operational metrics.
Smile Digital Health recently raised $30 million in Series B capital. The startup sells its health data fabric platform to providers, payers, digital health vendors and researchers. The platform gives customers the ability to store, search and evaluate patient information.
A panel of healthcare data experts recently broke down some of healthcare’s most common buzzwords at HLTH. While the experts agreed that many industry professionals still struggle to grasp the true denotations of words and phrases like “interoperability” and “reimagining healthcare,” the panelists said these terms can be quite meaningful once they’re unpacked.
Actions ranging from data theft to ransomware cost the healthcare industry over $9.2 million on average for every breach. Guidelines for making computing environments that house and utilize sensitive protected healthcare data more secure are highlighted in a new whitepaper by Ventech.
Full EHR interoperability and data standardization remain the holy grail: mysterious and elusive. So hospitals are employing different strategies to access a patient's complete medical history.
As we work to engage underserved communities in proactive, value-based medical treatment, we need to find ways to provide more granular data that accurately and precisely reflects the communities we serve. There is no more pressing issue than the advancement of care equity in a country so rife with disparities.
Providers, payers, and life sciences companies have a lot of room for growth using AI, and investors participating in JPM will continue to focus on companies that recognize this and act on it.
Data can liberate patients, but as a healthcare system we need to recognize the additional steps necessary in order to make them trust its value. That can only happen when the patient is able to say, “I understand.”
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
As news of Anthem’s massive hack from last week settled in, health IT and security experts further weighed in on the charged discussions surrounding healthcare cyber security and whether Anthem was adequately prepared for the attack. It was quickly noted in security circles that the insurer had failed to encrypt its data on some 80 […]
On the heals of a year fraught with high-profile data breaches, the risk is now greater than ever, and within healthcare, the threat is “persistent and growing” and could reach $5.6 billion next year, according to a report from Experian. It’s not hard to figure out why – an explosion of data and the realization that personal […]
If the rounds that Health Catalyst and Zephyr Health have put together are any indication of how the rest of the year might go for fledgling healthcare data analytics startups, we can expect to see bigger, mid-stage deals this year, and not in the places you might expect. New analysis from research firm CB Insights […]
When Orexigen Therapeutics needed to recruit some 9,000 patients for a clinical trial examining the cardiovascular effects of its weight loss drug candidate, big data came to the rescue. Only it wasn’t big healthcare data. Rather, the pharmaceutical company’s contractor, Blue Chip Marketing, mined consumer data to look for lifestyle clues that indicated certain people […]
Thompson Reuters will lend some of its scientific and clinical data and analysis methods to power startup NuMedii’s mission to find new uses for old drugs through a new strategic partnership. Stanford University spinout NuMedii has developed an analytics system that identifies high-potential new indications for FDA-approved drugs. It works with CROs to validate promising […]
